1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global burden of disease study 2010;Vos;Lancet,2013
2. The burden of musculoskeletal conditions;Palazzo;Plos One,2014
3. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis. Consensus development at OMERACT III;Bellamy;J Rheumatol,1997
4. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy;J Rheumatol,1988
5. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post-validation reapplication of the WOMAC osteoarthritis index;Bellamy;J Rheumatol,1992